Aanma Provides Commentary to Fda Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators
U.S. Newswire › December 11, 2008
Linked as:
Summary
To: NATIONAL EDITORS
Contact: Scott Lerman of the Allergy & Asthma Network Mothers of Asthmatics, +1-917-324-1719, slerman@aanma.orgSee the full content of this document
Extract
Aanma Provides Commentary to Fda Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators
FAIRFAX, Va., Dec. 11 /PRNewswire-USNewswire/ -- Nancy Sander, president and founder of Allergy & Asthma Network Mothers of Asthmatics (AANMA) today ur...
See the full content of this document
Sponsored links
